Univfy

About Univfy

Univfy operates at the intersection of artificial intelligence and healthcare, providing a predictive analytics platform for the fertility market. The company was founded in 2009 by Dr. Mylene Yao and Professor Wing H. Wong, originating from research conducted at Stanford University. Dr. Yao, the CEO, brings over 20 years of clinical and research experience in reproductive medicine, having served on the faculty at Stanford after completing her OB/GYN residency at McGill University and subspecialty training at Harvard University. Her co-founder, Professor Wong, is a distinguished statistician and computational biologist at Stanford, whose work laid the statistical groundwork for the company's technology.

The company’s core business model is B2B, primarily serving fertility clinics and providers. Univfy's AI platform analyzes a clinic's own outcomes data to develop and validate customized prediction models. This allows clinics to offer patients the Univfy PreIVF™ Report, a personalized assessment of their probability of having a baby through in vitro fertilization (IVF), often across multiple cycles. The reports are provided to patients by their doctors, typically free of charge, after a diagnostic workup is complete. By offering more precise, personalized success probabilities than traditional age-based estimates, Univfy helps manage patient expectations and supports shared decision-making. Revenue is generated by licensing the AI platform to these clinics, which in turn can experience increased patient retention and IVF conversion rates.

The key product is the Univfy AI Platform, which generates the personalized PreIVF™ Report. This report analyzes a comprehensive set of a patient's health data, including age, BMI, reproductive history, ovarian reserve test results, and semen analysis, and compares it against the clinic's specific historical data. This method has been shown to be more accurate than age-based predictions alone, identifying that over 50% of patients have a higher probability of success than previously thought. Beyond the report, the platform enables clinics to create and manage value-based financial programs, such as multi-cycle and refund warranty options. These programs cap the financial risk for patients, making treatment more accessible and encouraging them to commit to a course of treatment that maximizes their chances of success. Univfy has also expanded its services to collaborate with employers and health plans to bring more predictability to fertility treatment costs and outcomes.